Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie-Claude Renaud

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|July 2, 2022
Low BRCA1 and BRCA2 Germline Mutation Rates in a French-Canadian Population with a Diagnosis of Epithelial Tubo-Ovarian CarcinomaJuliette Bernard, Wala Mehros, Jean Gregoire, et al.
Oncotarget|February 8, 2014
Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylationZhi-Qiang Wang, Magdalena Bachvarova, Chantale Morin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 8, 2014
Visual and automated assessment of matrix metalloproteinase-14 tissue expression for the evaluation of ovarian cancer prognosisDominique Trudel, Patrice Desmeules, Stéphane Turcotte, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|March 12, 2014
Extensive adipose tissue necrosis following pfannenstiel incision for endometrial cancerMaryse Céline Lavoie, Marie Plante, Marie-Carine Lemieux, et al.
Diagnostic Pathology|September 19, 2018
Correction to: HtrA1 expression and the prognosis of high-grade serous ovarian carcinoma: a cohort study using digital analysisAndréanne Gagné, Bernard Têtu, Michèle Orain, et al.
Diagnostic Pathology|August 23, 2018
HtrA1 expression and the prognosis of high-grade serous ovarian carcinoma: a cohort study using digital analysisAndréanne Gagné, Bernard Têtu, Michèle Orain, et al.
Cell Cycle (Georgetown, Tex.)|February 28, 2013
The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasionMamadou Keita, Magdalena Bachvarova, Chantale Morin, et al.
Molecular Oncology|August 23, 2011
Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancerPierre-Luc Mercier, Magdalena Bachvarova, Marie Plante, et al.
Human Pathology|March 17, 2015
Prognostic significance of TIMP-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysisPatrice Desmeules, Dominique Trudel, Stéphane Turcotte, et al.
Oncotarget|February 13, 2016
The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cellsAdnen Faddaoui, Magdalena Bachvarova, Marie Plante, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|July 2, 2022
Low BRCA1 and BRCA2 Germline Mutation Rates in a French-Canadian Population with a Diagnosis of Epithelial Tubo-Ovarian CarcinomaJuliette Bernard, Wala Mehros, Jean Gregoire, et al.
Oncotarget|February 8, 2014
Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylationZhi-Qiang Wang, Magdalena Bachvarova, Chantale Morin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 8, 2014
Visual and automated assessment of matrix metalloproteinase-14 tissue expression for the evaluation of ovarian cancer prognosisDominique Trudel, Patrice Desmeules, Stéphane Turcotte, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|March 12, 2014
Extensive adipose tissue necrosis following pfannenstiel incision for endometrial cancerMaryse Céline Lavoie, Marie Plante, Marie-Carine Lemieux, et al.
Diagnostic Pathology|September 19, 2018
Correction to: HtrA1 expression and the prognosis of high-grade serous ovarian carcinoma: a cohort study using digital analysisAndréanne Gagné, Bernard Têtu, Michèle Orain, et al.
Diagnostic Pathology|August 23, 2018
HtrA1 expression and the prognosis of high-grade serous ovarian carcinoma: a cohort study using digital analysisAndréanne Gagné, Bernard Têtu, Michèle Orain, et al.
Cell Cycle (Georgetown, Tex.)|February 28, 2013
The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasionMamadou Keita, Magdalena Bachvarova, Chantale Morin, et al.
Molecular Oncology|August 23, 2011
Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancerPierre-Luc Mercier, Magdalena Bachvarova, Marie Plante, et al.
Human Pathology|March 17, 2015
Prognostic significance of TIMP-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysisPatrice Desmeules, Dominique Trudel, Stéphane Turcotte, et al.
Oncotarget|February 13, 2016
The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cellsAdnen Faddaoui, Magdalena Bachvarova, Marie Plante, et al.
Pageof 7